Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Cardiology · Pulmonary Hypertension

Does Pulmonary Hypertension Improve After Mitral Treatment?

At a Glance

Pulmonary hypertension caused by mitral valve stenosis often improves after the valve is opened or replaced, but it may not fully resolve. Long-term changes in lung vessels, residual valve problems, heart stiffness, or lung disease can keep pressures high and require follow-up.

In this answer

4 sections

01

Why Might Pulmonary Hypertension Persist?

02

Monitoring Your Heart After Treatment

03

Watching for Symptoms of Right-Heart Failure

04

Why Not Use Pulmonary Hypertension Drugs?

Yes, pulmonary hypertension—abnormally high pressure in the blood vessels of the lungs, which in this case is caused by pressure backing up from the left side of the heart—often improves after a successful procedure to open or replace a narrowed mitral valve [1]. When the valve is treated, the backup of pressure in the heart decreases, and pressure in the lungs usually drops [1].

However, the high pressure does not always go away completely, and improvement can be gradual rather than immediate [1]. For many patients, pulmonary pressures remain elevated because of long-lasting changes in the lung’s blood vessels or other heart and lung conditions [2] [3].

Why Might Pulmonary Hypertension Persist?

Even after the mitral valve is opened or replaced, several factors can cause high pressure in the lungs to stick around:

  • Pulmonary vascular remodeling: Years of high pressure backing up from the narrowed mitral valve can cause the blood vessels in the lungs to thicken and stiffen. This “remodeling” means the vessels cannot simply relax right away, even after the valve is fixed [3].
  • Residual valve issues: The procedure may leave behind a small amount of narrowing (residual stenosis) or a leaky valve (regurgitation), which continues to put pressure on the lungs [2].
  • Left-heart filling pressures: Sometimes the main pumping chamber of the heart (the left ventricle) remains stiff (diastolic dysfunction), meaning blood still has trouble filling the heart efficiently, causing pressure to back up into the lungs [4].
  • Lung disease: Other conditions like COPD (chronic obstructive pulmonary disease) or sleep apnea can independently keep lung pressures high [5].
  • Right-heart dysfunction: If the right side of the heart has struggled against high pressure for too long, it can become weak and struggle to adapt to the resistance in the lung blood vessels (a problem doctors call impaired right-ventricle–pulmonary-artery coupling) [6].

Monitoring Your Heart After Treatment

Because pulmonary hypertension can persist, ongoing monitoring is an essential part of your recovery. The exact schedule will be individualized by your care team based on your procedure, valve type, and symptoms [7]:

  • Follow-up Echocardiography (Ultrasound of the Heart): An early post-treatment ultrasound and periodic surveillance are commonly arranged [8]. This test allows your doctor to check the size of the heart chambers, see how well the repaired or replaced valve is working, and estimate the pressures in your lungs [9] [7]. However, an elevated estimate on an echocardiogram alone does not definitively confirm pulmonary hypertension [10].
  • Right-Heart Evaluation (Catheterization): If an echocardiogram does not give a clear enough picture or if your symptoms continue, your doctor may recommend a right-heart catheterization [10]. This invasive test directly measures the pressures in the lungs and heart with greater precision and helps distinguish whether the high pressure is coming from the left heart or the lung vessels themselves [11] [12].

Watching for Symptoms of Right-Heart Failure

When pulmonary hypertension persists, it puts a heavy strain on the right side of the heart [13]. This can eventually lead to right-heart failure [13].

URGENT WARNING: Seek emergency medical help immediately if you experience sudden or severe shortness of breath at rest, fainting, chest pain, blue or gray lips, confusion, or coughing up blood [14] [15]. These can be signs of serious, life-threatening complications.

For less severe, gradual changes, contact your doctor promptly if you notice:

  • Worsening shortness of breath, especially when exercising or moving around [13] [16]
  • Unusual tiredness or a noticeable drop in your ability to do physical activities [13]
  • New or worsening swelling in your legs, ankles, or feet (edema) [17]
  • Swelling or a feeling of fullness in your abdomen, which can be caused by liver congestion [11] [17]
  • Swollen veins in your neck [17]

Keep in mind that worsening breathlessness is not specific to pulmonary hypertension; it could also mean your valve issue has returned, or you have an arrhythmia, infection, or blood clot [14] [18].

Why Not Use Pulmonary Hypertension Drugs?

If you have persistent high pressure in your lungs, you might wonder why doctors don’t simply prescribe medications designed specifically for pulmonary hypertension.

The reason is that pulmonary hypertension caused by left-heart disease (like mitral stenosis) works differently than pulmonary arterial hypertension (PAH), which is a disease of the lung vessels themselves. Clinical trials have shown that specific PAH drugs do not provide a clear benefit for pulmonary hypertension caused by left-heart disease, and they can sometimes cause harm [19] [4]. For instance, studies have found that these medications can increase the risk of worsening heart failure or fluid buildup in this specific population [20].

Because of this, current medical guidelines do not recommend using PAH-targeted drugs for pulmonary hypertension caused by mitral valve disease outside of specialist-directed evaluation or clinical trials [21] [22]. Instead, doctors focus on managing the underlying heart valve issue, treating any other contributing conditions, and sometimes using diuretics (water pills) to manage fluid buildup [21] [23]. Never start or stop medications without consulting your care team.

Common questions in this guide

Can pulmonary hypertension return to normal after mitral valve stenosis treatment?
It often improves after a successful procedure that opens or replaces the narrowed mitral valve, because pressure backing up from the heart decreases. It may take time to improve, and some people continue to have elevated pressure because the lung vessels or heart have undergone lasting changes.
Why might my lung pressure stay high after my mitral valve is treated?
Persistent pressure can result from thickened or stiff lung vessels, residual narrowing or leakage of the mitral valve, or a stiff left ventricle. COPD, sleep apnea, and right-sided heart weakness can also contribute.
How do doctors check for pulmonary hypertension after valve treatment?
An echocardiogram checks the treated valve and estimates pressure in the lungs, but an estimate alone does not confirm pulmonary hypertension. If the result is unclear or symptoms continue, a right-heart catheterization, an invasive pressure test, can directly measure pressures and help identify their source.
Are pulmonary hypertension medicines used when mitral stenosis caused the problem?
Medicines made for pulmonary arterial hypertension are generally not recommended for pulmonary hypertension caused by left-heart disease such as mitral stenosis, because they have not shown clear benefit and can sometimes worsen heart failure or fluid buildup. Doctors usually focus on the valve problem, other contributing conditions, and diuretics when fluid buildup is present.
Which symptoms after treatment need emergency help?
Call emergency services for sudden or severe shortness of breath at rest, fainting, chest pain, blue or gray lips, confusion, or coughing up blood. Contact your doctor promptly for worsening activity-related breathlessness, new swelling in the legs or abdomen, sudden weight gain, or swollen neck veins.

Related questions

Which Exercise Is Safe With Mitral Valve Stenosis? How Does Mitral Valve Stenosis Cause Atrial Fibrillation? How Does Mitral Valve Stenosis Affect Life Expectancy? What Medications Are Used for Mitral Valve Stenosis? How Rheumatic Fever Causes Mitral Valve Stenosis Years Later
Show more
How Fast Does Mitral Valve Stenosis Progress Over Time? What Diet and Fluid Limits Apply to Mitral Valve Stenosis? Need a Blood Thinner for Mitral Stenosis in Sinus Rhythm? What Can Suddenly Worsen Symptoms of Mitral Valve Stenosis? Why Do Mitral Stenosis Valve Area and Gradient Disagree? Can Mitral Stenosis Cause Right-Sided Heart Failure? How Common Is Mitral Valve Stenosis and Who Gets It? Can Congenital Mitral Valve Stenosis Occur and Be Treated? How do doctors determine the cause of mitral valve stenosis? How Does Mitral Valve Stenosis Increase Stroke Risk? What Is Calcific Mitral Stenosis from Calcium Buildup? When Mitral Stenosis Symptoms and Echo Differ: Which Tests? When Are CT and Catheterization Used for Mitral Stenosis? Why Is a TEE Done Before Mitral Balloon Valvotomy?

Get notified when new evidence is published on mitral valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Efficacy and safety of percutaneous mitral balloon valvotomy in patients with mitral stenosis: A systematic review and meta-analysis.

    Abu Rmilah AA, Tahboub MA, Alkurashi AK, et al.

    International journal of cardiology. Heart & vasculature 2021; (33()):100765 doi:10.1016/j.ijcha.2021.100765.

    PMID: 33889711
  2. 2

    Predictors of Very Late Events After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis.

    Jorge E, Pan M, Baptista R, et al.

    The American journal of cardiology 2016; (117(12)):1978-84.

    PMID: 27131615
  3. 3

    Pulmonary Hypertension in Aortic and Mitral Valve Disease.

    Maeder MT, Weber L, Buser M, et al.

    Frontiers in cardiovascular medicine 2018; (5()):40 doi:10.3389/fcvm.2018.00040.

    PMID: 29876357
  4. 4

    Study on the clinical efficacy of specific phosphodiesterase inhibitor in patients with pulmonary hypertension due to left heart disease.

    Han B, Wang Q

    Experimental and therapeutic medicine 2018; (16(2)):1175-1186 doi:10.3892/etm.2018.6310.

    PMID: 30112056
  5. 5

    Degenerative Mitral Stenosis Versus Rheumatic Mitral Stenosis.

    Pressman GS, Ranjan R, Park DH, et al.

    The American journal of cardiology 2020; (125(10)):1536-1542 doi:10.1016/j.amjcard.2020.02.020.

    PMID: 32241552
  6. 6

    The impact of baseline right ventricular-pulmonary artery coupling on the short-term outcome after valve replacement surgery for rheumatic mitral stenosis.

    Li Y, Cai Y, Zhang X, et al.

    Quantitative imaging in medicine and surgery 2025; (15(12)):12006-12017 doi:10.21037/qims-2025-1380.

    PMID: 41367807
  7. 7

    Analysis of Long-Term Effects of Percutaneous Balloon Mitral Valvotomy (PBMV) in 90 Patients With Rheumatic Mitral Stenosis: A Retrospective Analysis.

    Xu J, Liang N, Xiao Y, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026; (108(1)):124-129 doi:10.1002/ccd.70576.

    PMID: 42013245
  8. 8

    Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography.

    Pandian NG, Kim JK, Arias-Godinez JA, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2023; (36(1)):3-28 doi:10.1016/j.echo.2022.10.009.

    PMID: 36428195
  9. 9

    Reversal of abnormal cardiac parameters following mitral valve replacement for severe mitral stenosis in relation to pulmonary artery pressure: A retrospective study of noninvasive parameters - Early and late pattern.

    Parvathy UT, Rajan R, Faybushevich AG

    Interventional medicine & applied science 2016; (8(2)):49-59 doi:10.1556/1646.8.2016.2.1.

    PMID: 28386460
  10. 10

    Correlation between Pulmonary Artery Pressure Measured by Echocardiography and Right Heart Catheterization in Patients with Rheumatic Mitral Valve Stenosis (A Prospective Study).

    Sohrabi B, Kazemi B, Mehryar A, et al.

    Echocardiography (Mount Kisco, N.Y.) 2016; (33(1)):7-13 doi:10.1111/echo.13000.

    PMID: 26096532
  11. 11

    Progressive Right-Sided Heart Failure and Secondary Tricuspid Valve Disease in Pediatric Lutembacher Syndrome: A Case Report.

    Hayes CC, Chodos K, Stefek BP

    Case reports in cardiology 2026; (2026()):1744460 doi:10.1155/cric/1744460.

    PMID: 42328660
  12. 12

    Pulmonary Hypertension: A Brief Guide for Clinicians.

    Mandras SA, Mehta HS, Vaidya A

    Mayo Clinic proceedings 2020; (95(9)):1978-1988 doi:10.1016/j.mayocp.2020.04.039.

    PMID: 32861339
  13. 13

    Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.

    Konstam MA, Kiernan MS, Bernstein D, et al.

    Circulation 2018; (137(20)):e578-e622 doi:10.1161/CIR.0000000000000560.

    PMID: 29650544
  14. 14

    Revisiting Acute Decompensated Right Ventricle Failure in Pulmonary Arterial Hypertension.

    Masih R, Paudyal V, Basnet YM, et al.

    The open respiratory medicine journal 2025; (19()):e18743064359315 doi:10.2174/0118743064359315250210080743.

    PMID: 40322493
  15. 15

    Management of Acutely Decompensated Pulmonary Hypertension.

    Savale L, Kularatne M, Roche A, et al.

    Seminars in respiratory and critical care medicine 2023; (44(6)):762-770 doi:10.1055/s-0043-1770119.

    PMID: 37369216
  16. 16

    Molecular Hydrogen Therapy for SLE-PAH: Case Report on Immune Marker Modulation.

    Tu TH, Lu JW, Wu CH, et al.

    In vivo (Athens, Greece) 2025; (39(2)):1211-1219 doi:10.21873/invivo.13926.

    PMID: 40010970
  17. 17

    Chronic Right Heart Failure: Pathogenesis, Haemodynamic Foundations, and a Pragmatic Diagnostic Algorithm.

    Dini FL, Palazzuoli A, Carluccio E, et al.

    Journal of cardiovascular development and disease 2026; (13(7)) doi:10.3390/jcdd13070317.

    PMID: 42505894
  18. 18

    Managing a Critically Ill Patient With Pulmonary Arterial Hypertension.

    Sulica R, De Marco T, Elwing JM, et al.

    Chest 2026; (170(4)):1260-1271 doi:10.1016/j.chest.2026.05.018.

    PMID: 42176848
  19. 19

    [Pulmonary hypertension associated with left heart disease (group 2)].

    Schmidt KH, Bikou O, Blindt R, et al.

    Pneumologie (Stuttgart, Germany) 2023; (77(11)):926-936 doi:10.1055/a-2145-4792.

    PMID: 37963482
  20. 20

    Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis.

    Cao JY, Wales KM, Cordina R, et al.

    International journal of cardiology 2018; (273()):213-220 doi:10.1016/j.ijcard.2018.09.043.

    PMID: 30224253
  21. 21

    Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension.

    Martinez C, Tsugu T, Sugimoto T, Lancellotti P

    Current cardiology reports 2019; (21(12)):151 doi:10.1007/s11886-019-1240-7.

    PMID: 31768665
  22. 22

    Pulmonary hypertension associated with left heart disease.

    Maron BA, Bortman G, De Marco T, et al.

    The European respiratory journal 2024; (64(4)) doi:10.1183/13993003.01344-2024.

    PMID: 39209478
  23. 23

    Pulmonary Hypertension in the Intensive Care Unit.

    Jentzer JC, Mathier MA

    Journal of intensive care medicine 2016; (31(6)):369-85 doi:10.1177/0885066615583652.

    PMID: 25944777

This page is for informational purposes only and does not constitute medical advice. Your cardiology team should interpret your follow-up pressures, test results, symptoms, and medication needs.